Concepedia
Statistics
Publications
13
Citations
290
H-Index
12
Active since
2008
Affiliations
Georgetown University(Current)
Georgetown University Medical Center
Thomas Jefferson University
Saint John's Health Center
Duke University Hospital
Venkata Mahidhar Yenugonda is an author at Georgetown University specializing in pharmacology, oncology, and molecular oncology.
Publications per year
2008–2020
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells
Lymor Ringer, Paul Sirajuddin, Lucas Tricoli et al. · Oncotarget · 2014 · 42 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue
Sung Hee Hwang, Antonina Rait, Kathleen F. Pirollo et al. · Molecular Cancer Therapeutics · 2008 · 39 citations
Pharmacy, Oncology, Pharmacology +17
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma
Venkata Mahidhar Yenugonda, Natsuko Nomura, Valentina L. Kouznetsova et al. · Journal of Translational Medicine · 2017 · 28 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells
Venkata Mahidhar Yenugonda, Tushar B. Deb, Scott Grindrod et al. · Bioorganic & Medicinal Chemistry · 2011 · 24 citations
Life Sciences, Cell Biology, Oncology +14
The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells
Sarah Waye, Aisha Naeem, Muhammad Umer Choudhry et al. · Aging · 2015 · 23 citations · Full text
Life Sciences, Cancer Biology, Oncology +16
1–5 of 13